Self-Help

Figures converted from ILS at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged. NICE reports its financial statements in US dollars; only the Tel Aviv share price and the market value derived from it are converted here.

Self-Help

NICE enters the dislocation debt-free: the $460 million 0% notes were repaid at maturity in September 2025, leaving only $88.8 million of operating leases against $417 million of cash plus an undrawn $300 million revolver [1][2]. The buyback engine is real and accelerating — $145M to $489M across 2022–2025, a record $253 million in Q1 2026, over half of free cash flow committed [3][4]. Share count is falling; stock-based compensation and acquisitions make adjusted capacity thinner than headline FCF suggests.

The balance sheet against the problem's duration

The framework's question here is whether the company can outlast a multi-year problem without capital allocation being forced toward debt paydown at the moment repurchases matter most. For NICE the answer is unambiguous, because the debt is already gone.

Source: FY2025 Annual Report (Form 20-F), Consolidated Balance Sheets [5], Statements of Cash Flows [6], and the Credit Agreement disclosure [7].

The one piece of financial debt NICE carried into this period was $460 million of 0% exchangeable senior notes due 2025. They bore no interest and did not accrete; they fully matured on September 15, 2025 and were settled in cash for $460 million, with no conversion value above principal [8]. On the balance sheet the effect is stark: the "Debt" line reads zero at December 31, 2025, against $458.8 million a year earlier [9].

A genuine year-by-year maturity schedule is therefore short:

Maturity	Financial debt	Detail
2025	$460M	0% exchangeable notes — settled in cash at maturity, Sept 15, 2025
2026 and after	$0	No financial debt outstanding
Operating leases	$88.8M total	$13.7M current, $75.1M long-term; 7.6-yr weighted term at 4.78%

Source: FY2025 Annual Report (Form 20-F), debt and lease footnotes [10][11][12].

There is no covenant that binds, because there is nothing drawn to covenant against: on February 20, 2026 NICE closed a new senior secured revolving facility of $300 million with JPMorgan, guaranteed by its U.S. subsidiaries — additional headroom, undrawn [13]. Refinancing risk at current rates does not apply when there is nothing to refinance.

The one qualification is that the liquid cushion is thinner than the headline zero-debt read implies. NICE ran its cash and short-term investments down from $1.62 billion at the end of 2024 to $417 million at the end of 2025, spending the difference on the $460 million note repayment, the Cognigy acquisition, and buybacks [14][15]. Even so, zero debt, a $300 million undrawn revolver, and more than $600 million of annual free cash flow mean allocation is not forced toward the balance sheet. NICE can comfortably outlast a multi-year problem with repurchases still on the table.

The repurchase record — executed, not authorized

This is not an authorization sitting unused. Cash actually spent on buybacks has risen every year, and the programs have been executed to completion, not announced and left idle.

Source: FY2025 Annual Report (Form 20-F), Consolidated Statements of Cash Flows, "Purchase of treasury shares" [16].

The $500 million program authorized in June 2024 was fully executed by December 31, 2025; the Board then authorized a further $500 million in May 2025 and another $600 million in February 2026 [17]. In 2025 NICE bought back 3,636,837 ADRs at an average price of $134.43, working down from $170 in January to $108.63 in December as the shares fell [18]. That average sits roughly 41% above today's ADR near $95 — so the bulk of the recent repurchases were done richer than the current quote, and the accelerating pace into the drawdown is now buying stock materially cheaper.

The share count is falling, which clears the framework's hard-fail bar — a rising count driven by SBC or serial issuance is not present here.

Fiscal year-end	Buyback cash	Avg price paid	Shares (feature basis)	Shares outstanding (20-F)
2022	$144.9M	—	66.5M	—
2023	$288.4M	—	66.3M	—
2024	$369.2M	—	65.5M	63.2M
2025	$488.9M	$134.43	63.3M	60.4M
Q1 2026	$253M (record)	—	—	~58.5M

Sources: share-count trajectory from fit_features.share_count_trend; period-end outstanding and average price from the FY2025 Annual Report (Form 20-F) [19][20]; Q1 2026 figures from the Q1 2026 earnings call [21].

Two caveats keep this honest. First, the net reduction has been modest: on the feature basis the count fell from 66.5 million to 63.3 million over three years, about 1.6% a year, because stock-based compensation of $146–182 million annually replaces roughly half of what the buybacks retire [22], and the 2025 Cognigy deal added ADSs for part of the consideration (management calls the dilution immaterial). Second, the two share series differ: the deterministic feature uses 63.3 million for FY2025, while the 20-F reports 60.4 million ordinary shares actually outstanding at year-end and management cited approximately 58.5 million by the end of March 2026 after the record quarter [23][24]. The Q1 2026 pace — a 5% year-over-year decline in shares, and repurchases equal to 3.5% of market value in a single quarter — is far quicker than the multi-year average, helped by the lower price.

Management's buyback intent, from the record

The buyback question is asked on every call, and management's answer has hardened as the balance sheet cleared. On the Q1 2026 call the CFO stated NICE "remain[s] committed to our share repurchases exceeding 50% of our free cash flow this year," having just executed "a record $253 million of shares representing 3.5% of our market capitalization," and exited the quarter with $745 million of buyback still authorized [25]. On the Q4 2025 call management framed the setup as "a strong balance sheet that supports investment and continued capital returns to our shareholders" [26]. Capital return has been a persisted theme across the call history — buybacks scaled steadily while the debt was retired — rather than a new talking point.

At the current roughly 10% free-cash-flow yield (see Yield), a commitment to return more than half of free cash flow translates to a buyback of roughly 5% of market value a year at these prices — before any operating growth. That is the flywheel the dislocation is meant to supply; NICE has both the capacity and the stated intent to run it.

The levered exception does not apply

The framework's levered-path exception is reserved for cases where the adjusted yield is very high — on the order of 25% or more — and demands three legs together: a massive yield, a demonstrated multi-year share-count reduction, and FCF/revenue that is not deteriorating. NICE's free-cash-flow yield is near 10%, not 25%-plus, so the exception is not in play and the ordinary fortress-or-moderate reading governs. NICE clears that ordinary reading on the balance-sheet leg; the yield magnitude is the Yield tab's to weigh.

The absurdity check

The deterministic float_retirement_years feature is not_computable because the reporting currency (USD) and the price currency (ILS) do not match and the FX conversion was not attempted in the feature build. Converting the market value to dollars closes that gap. At about $95 per ADR on roughly 63.3 million shares, NICE is worth about $6.0 billion. Against FY2025 free cash flow of $622.8 million, that is:

$6.0 billion ÷ $622.8 million ≈ 9.7 years of free cash flow to retire the entire float.

On management's more recent share count near 58.5 million, the market value is closer to $5.6 billion and the figure drops to roughly 9 years.

The number does more work once adjusted. Netting only stock-based compensation ($146.0 million) lifts the payback to about 12.6 years [27]. NICE's acquisition habit stretches it further: cash paid for businesses was $415 million in 2023, $65 million in 2024, and $856 million in 2025 (Cognigy), averaging roughly $445 million a year over that window [28]. The framework's adjusted FCF nets a multi-year average of that spend, which compresses the figure toward break-even in a heavy acquisition year. Because the Cognigy purchase is lumpy and no clean five-year window exists, adjusted FCF is itself not_computable; the raw ~10-year payback is the reliable anchor, and the acquisition drag is the swing factor the Yield tab carries.

Dividend safety

NICE pays no ordinary dividend and states it has "no plans at this time to make any future dividend payments" [29]. The dividend yield is zero and forms no part of the return case, which rests entirely on the buyback flywheel above; dividend cover is therefore not applicable.

Management credibility

The promise-versus-delivery record is mixed but not promotional. Management tends to hit the conservative guides it sets at the start of a year and to overreach on the mid-year raises.

Promise (call)	What was said	Outcome
FY2024 cloud growth (Q2 2024)	~18% organic cloud, ex-LiveVox	Missed — cut to 16%–17% one quarter later
FY2025 cloud growth (Q4 2024)	+12%	Kept — finished about 13%
FY2025 EPS (Q4 2024)	$12.13–$12.33	Kept — landed at $12.30
FY2025 EPS raise (Q2 2025)	raised to $12.33–$12.53	Missed — trimmed for Cognigy dilution; $12.30, below the raised floor
FY2026 cloud growth (Q4 2025)	14.5%–15%	Walked back to 13%–15% one quarter later

Sources: NICE quarterly earnings calls, Q2 2024 [30], Q3 2024 [31], Q4 2024 [32], Q2 2025 [33], Q4 2025 [34], Q1 2026 [35]; FY2025 EPS outcome from the Q4 2025 call [36].

Two of the five promises were missed, but each miss has a benign cause on the record — elongated enterprise deployment ramps in 2024, and Cognigy acquisition dilution against the 2025 raise — rather than an operational shortfall dressed up. The one language flag worth stating plainly: on the Q1 2026 call, management reframed a discount-driven cut to its own cloud guidance as "playing offense," insisting the marquee-customer repricing was proactive rather than a concession to buyer pressure [37]. That is a promotional tell to note, not a pattern; the earlier Russell-led calls leaned on "prudent guidance" hedging instead [38].

On alignment, insider economic ownership is low. Directors and executive officers together beneficially owned 407,795 shares — about 0.7% of the company — at February 18, 2026, with no individual owning 1% or more, and vested option and RSU exercise prices averaging $86.15 [39]. There is no controlling shareholder; the two holders above 5% are passive institutions (Principal at 7.9%, Harel at 5.3%) [40]. Governance is clean — eight independent directors, chairman and CEO roles held by different people — but the thin insider stake means management's economic skin is in compensation, weighted to equity, rather than in a founder-sized holding. Taken together: a credible, non-promotional record with a noted habit of over-optimistic mid-year raises and low insider ownership — not a framework exclusion.